Infliximab, a tumor necrosis factor-alpha inhibitor, is increasingly used for the therapy of different inflammatory conditions. We report the first case of cryptococcal meningitis in a patient treated with infliximab and other immunosuppressive agents, and review a further 5 reported cryptococcal infections. All of them involved fungal pneumonia. Outcome was favorable in all cases.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.diagmicrobio.2006.10.014 | DOI Listing |
Publication Analysis
Top Keywords
cryptococcal meningitis
8
meningitis patient
8
patient treated
8
treated infliximab
8
infliximab infliximab
4
infliximab tumor
4
tumor necrosis
4
necrosis factor-alpha
4
factor-alpha inhibitor
4
inhibitor increasingly
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!